The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per The Business Research Company’s Pancreatic Cancer Drugs Global Market Report 2023, the pancreatic cancer drugs market is expected to show significant growth in the forecast period.

Key insights from the pancreatic cancer drugs market forecast include:

1. Market Size

The global pancreatic cancer drugs market is expected to grow from $3.72 billion in 2022 to $3.91 billion in 2023 at a compound annual growth rate (CAGR) of 5.0%. The market size of the global pancreatic cancer drugs is expected to grow to $4.60 billion in 2027 at a CAGR of 4.1%.

2. Major Driver

The increasing prevalence of pancreatic cancer is expected to drive the growth of the pancreatic cancer drugs market. With the rise in several pancreatic cancer cases, the demand for drugs is expected to increase as well, which will drive the growth of the pancreatic cancer drugs market. The number of cancer cases has increased mainly due to the aging population and an increase in several people suffering from obesity. For instance, according to the American Cancer Society, in 2021, around 60,430 people (28,480 women and 31,950 men) are diagnosed with pancreatic cancer and approximately 48,220 people (22,950 women and 25,270 men) died from this cancer.

View More On The Pancreatic Cancer Drugs Market Report 2023 – https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report

3. Key Trend

The concept of combination therapy over monotherapy is one of the latest ongoing trends in the pancreatic cancer drugs market. Major players in the market understand that the combination of two or more drugs is a suitable way to increase the efficacy of the drugs and thus increase the rate of survival of patients being diagnosed with pancreatic cancer. Some of the companies investing in the combination therapy are Rafael Pharmaceuticals announced the initiation of the Pivotal Phase 3 Trial (AVENGER 500) of CPI-613 (delimitate) in combination with Modified FOLFIRINOX as first-line treatment for patients with Metastatic Pancreatic Cancer and Apexigen, Inc., a clinical-stage biopharmaceutical company, announced the presentation of new clinical data on APX005M in combination therapy in patients with metastatic pancreatic cancer.

4. Largest Region

North America was the largest region in the pancreatic cancer drugs market in 2022.

5. Major Players

Major players in the pancreatic cancer drugs market are Eli Lilly and Company, F. Hoffman LA Rouch, Clovis Oncology, Pfizer, Novartis AG, Amgen, Celegene Corporation, AB Science, GlaxoSmithKline and Abbvie Inc.

Request A Sample Of The Global Pancreatic Cancer Drugs Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2565&type=smp

Key Pancreatic Cancer Drugs Market Segments
The global pancreatic cancer drugs market is segmented –
1) By Type: Endocrine Pancreatic Cancer, Exocrine Pancreatic Cancer
2) By End User: Hospitals, Clinics, Other End-Users
3) By Drugs: Afinitor, Erlotinib, Hydrochloride Everolimus, 5-FU, Flurouracil, Gemcitanine, Abraxane

The Pancreatic Cancer Drugs Global Market Report 2023  provides an in-depth analysis on the pancreatic cancer drugs market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the pancreatic cancer drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Drugs For Immunotherapy Global Market Report 2023
Cancer Biologics Global Market Report 2023
Cancer Diagnostics Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model